Since reforms were implemented to control Philadelphia’s mass tort pharmaceutical and asbestos filings, they have apparently fallen 60 percent. in a new report, Judge John Herron  associates the “inventory reduction” with reforms adopted in February 2012.

Among them were a prohibition on mass-tort case consolidation without an agreement of all the  parties, requiring that discovery take place in Philadelphia, limitations on the number of trials  that can be tried by pro hac vice counsel, and a mandate deferring punitive damages in asbestos  cases. Other report data note that out-of- state asbestos plaintiffs filed 33 percent of new  asbestos cases in 2013, compared to 44 percent in 2012. Out-of-state pharmaceutical plaintiffs  filed 89 percent of all new pharmaceutical cases in 2013, up 3 percent from 2012.